Article

Favorable outcomes achieved after toric IOL implantation in post-penetrating keratoplasty eyes

Implantation of a toric IOL appears to be a safe and effective method for correcting spherical error and astigmatism in eyes with cataract and a history of penetrating keratoplasty, said Renée D. Solomon, MD.

Implantation of a toric IOL appears to be a safe and effective method for correcting spherical error and astigmatism in eyes with cataract and a history of penetrating keratoplasty, said Renée D. Solomon, MD.

Dr. Solomon presented outcomes from a prospective study of 10 eyes of 8 patients implanted with a toric IOL after surgery for a visually significant cataract. Inclusion criteria required that the eyes have refractive cylinder between 1 and 5 D after penetrating keratoplasty and have had the graft sutures removed at least 3 months previously. Eric Donnenfeld, MD, performed all of the cataract surgeries.

All eyes experienced improvements in best-corrected visual acuity (BCVA) and cylinder and statistically significant improvements were found in the mean values for both parameters. Mean BCVA improved from 20/70 preoperatively to 20/25 postoperatively. Mean cylinder improved from 3.37 to 1.27 D.

"We believe the reduction in cylinder achieved in these patients represents a significant improvement and supports further study of the implantation of toric IOLs as a method for visual rehabilitation of refractive errors in post-penetrating keratoplasty eyes with visually significant cataracts," Dr. Solomon said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.